MARKET

YTEN

YTEN

Yield10
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.64
+0.43
+5.96%
Closed 17:44 09/18 EDT
OPEN
7.21
PREV CLOSE
7.21
HIGH
7.65
LOW
7.04
VOLUME
223.86K
TURNOVER
--
52 WEEK HIGH
31.05
52 WEEK LOW
3.500
MARKET CAP
21.53M
P/E (TTM)
-0.3579
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
The Shortened Week Provides No Shortage Of Volatility
It’s been another up-and-down week for my trading account. Every day has been similarly choppy through most of the stocks I traded, but the end result from each one has been pretty different.
Benzinga · 09/11 17:12
Mid-Afternoon Market Update: Nasdaq Tumbles 200 Points; Satsuma Pharmaceuticals Shares Plunge
Toward the end of trading Thursday, the Dow traded down 1.32% to 27572.71 while the NASDAQ fell 1.83% to 10,937.98. The S&P also fell, dropping 1.61% to 3,344.11.
Benzinga · 09/10 18:31
Mid-Day Market Update: Dow Falls 50 Points; Virtusa Shares Spike Higher
Midway through trading Thursday, the Dow traded down 0.18% to 27,889.42 while the NASDAQ rose 0.35% to 11,180.98. The S&P also fell, dropping 0.08% to 3,396.20.
Benzinga · 09/10 16:06
Mid-Morning Market Update: Markets Open Higher; RH Tops Q2 Expectations
Following the market opening Thursday, the Dow traded up 0.57% to 28099.81 while the NASDAQ rose 1.41% to 11298.53. The S&P also rose, gaining 0.71% to 3,423.16.
Benzinga · 09/10 14:20
Benzinga's Top Upgrades, Downgrades For September 10, 2020
Upgrades * According to Barclays, the prior rating for Howmet Aerospace Inc (NYSE: HWM) was changed from Underweight to Overweight. For the second quarter, Howmet Aerospace had an EPS of $0.12, compared to year-ago quarter EPS of $0.58. At the moment, the stock has a 52-week-high of $18.99 and a 52
Benzinga · 09/10 13:31
Yield10 Bioscience Announces Participation at The H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16, 2020 (Virtual Conference)
WOBURN, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced it will be featured as a presenting company at the H.C. Wainwright 22nd Annual Global Investment Conference. The conference is being held on September 14-16,
GlobeNewswire · 09/09 13:30
Yield10 Bioscience to Present at the LD 500 Virtual Conference on September 2, 2020
WOBURN, MA / ACCESSWIRE / August 27, 2020 / Yield10 Bioscience, Inc.
ACCESSWIRE · 08/27 13:00
Yield10 Bioscience Announces Closing of $4.0 Million Public Offering, Including Exercise of the Over-Allotment Option, and Concurrent $1.7 Million Private Placement
WOBURN, Mass., Aug. 26, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced the closing of its previously announced underwritten public offering of 835,000 shares of its common stock at a public offering price of $4.25 per share.  In addition
GlobeNewswire · 08/26 17:00
More
Forecast
EPSBVPSCFPS
Actual (K USD)
Estimate (K USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average YTEN stock price target is 17.50 with a high estimate of 25.00 and a low estimate of 12.00.
EPS
Institutional Holdings
Institutions: 18
Institutional Holdings: 794.65K
% Owned: 28.20%
Shares Outstanding: 2.82M
TypeInstitutionsShares
Increased
1
1.99K
New
1
-83
Decreased
2
3.36K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+1.07%
Pharmaceuticals & Medical Research
+0.57%
Key Executives
Chairman/Director
Robert Van Nostrand
President/Chief Executive Officer/Director
Oliver Peoples
Chief Accounting Officer/Vice President - Finance
Charles Haaser
Vice President
Lynne Brum
Vice President
Kristi Snell
General Counsel/Secretary
Sarah Cecil
Director
Sherri Brown
Director
Richard Hamilton
Director
Joseph Shaulson
Independent Director
Anthony Sinskey
  • Dividends
  • Splits
  • Insider Activity
No Data

Analyst Price Target

The average YTEN stock price target is 17.50 with a high estimate of 25.00 and a low estimate of 12.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About YTEN
Yield10 Bioscience, Inc., formerly Metabolix, Inc., is an agricultural bioscience company. The Company is focused on developing disruptive technologies for step-change improvements in crop yield for food and feed crops to enhance global food security. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism to direct more carbon to seed production, the Company is advancing several yield traits it has developed in crops, such as Camelina, canola, soybean and corn. The Company concentrates on technologies that enables it to improve carbon dioxide fixation efficiency in photosynthesis and its direction to and conversion into plant matter. The Company has an additional agricultural science facility with greenhouses in Saskatoon, Saskatchewan, Canada.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Yield10 Bioscience Inc stock information, including NASDAQ:YTEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, YTEN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading YTEN stock methods without spending real money on the virtual paper trading platform.